Edition:
India

Alnylam Pharmaceuticals Inc (ALNY.OQ)

ALNY.OQ on NASDAQ Stock Exchange Global Select Market

88.63USD
1:30am IST
Change (% chg)

$-1.61 (-1.78%)
Prev Close
$90.24
Open
$90.40
Day's High
$90.92
Day's Low
$87.99
Volume
156,744
Avg. Vol
317,571
52-wk High
$153.80
52-wk Low
$60.28

Select another date:

Wed, Mar 6 2019

Side effects of Alnylam's gene-silencing drug raise concerns, shares slip

Alnylam Pharmaceuticals Inc's late-stage trial data on its new gene silencing drug cast doubt on its safety, even as results revealed its effectiveness in treating a rare, painful disease.

UPDATE 2-Side effects of Alnylam's gene-silencing drug raise concerns, shares slip

March 6 Alnylam Pharmaceuticals Inc's late-stage trial data on its new gene silencing drug cast doubt on its safety, even as results revealed its effectiveness in treating a rare, painful disease.

Alnylam's gene-silencing drug meets main goal in late-stage study

March 6 Alnylam Pharmaceuticals Inc said on Wednesday its gene-silencing drug for treating a rare, painful disease met the main goal in a late-stage trial.

Early approval of Alnylam's gene-silencing drug in question

Alnylam Pharmaceuticals Inc said on Thursday it might have to hold off on plans to seek an accelerated approval for its gene-silencing drug, which showed effectiveness in a late-stage trial based on early data.

UPDATE 4-Early approval of Alnylam's gene-silencing drug in question

* Co still plans to discuss potential early approval with FDA

Select another date: